Skip to main content

Table 3 Number (%) of Criteria Resulting in Ineligibility for Trials

From: Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials

No of Criteria No of Patients E1594 No of Patients SWOG9509
Resulting in Ineligibility Prospective Data
N = 100 (%)
Retrospective Data
N = 85 (%)
Entire Cohort
N = 185(%)
Prospective Data
N = 100 (%)
Retrospective Data
N = 85 (%)
Entire Cohort
N = 185 (%)
1 32 (32%) 38 (45%) 71 (38%) 34 (34%) 41 (48%) 75 (40.5%)
2 22 (22%) 11 (13%) 33 (18%) 23 (23%) 12 (14%) 35 (19%)
3 6 (6%) 9 (11%) 15 (8%) 7 (7%) 11 (13%) 18 (10%)
4 1 (1%) 2 (2%) 3 (2%) 2 (2%) 2 (2%) 4 (2%)
  1. * Eligibility for TAX326 is almost identical to SWOG9509 and so is not listed separately